Determinations of cerebral glucose utilization in dementia using positron emission tomography.
作者信息
Kuhl D E, Metter E J, Riege W H, Hawkins R A
出版信息
Dan Med Bull. 1985 Feb;32 Suppl 1:51-5.
PMID:3872772
Abstract
摘要
相似文献
1
Determinations of cerebral glucose utilization in dementia using positron emission tomography.
Dan Med Bull. 1985 Feb;32 Suppl 1:51-5.
2
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Am J Psychiatry. 1982 Mar;139(3):352-3. doi: 10.1176/ajp.139.3.352.
3
Positron emission tomography as an imaging tool in psychiatric disorders.
Psychiatry Res. 1989 Sep;29(3):351-2. doi: 10.1016/0165-1781(89)90086-3.
4
[Functional significance of calcinosis of the basal ganglia via positron emission tomography].
Fortschr Neurol Psychiatr. 1994 Apr;62(4):119-24. doi: 10.1055/s-2007-996663.
5
Functional imaging in dementia: an overview.
J Clin Psychiatry. 1994 Nov;55 Suppl:5-11.
6
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
J Neuropsychiatry Clin Neurosci. 1992 Summer;4(3):239-48. doi: 10.1176/jnp.4.3.239.
7
Characteristics of cerebral glucose utilization in dementia.
Sci Rep Res Inst Tohoku Univ Med. 1990 Dec;37(1-4):11-21.
8
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
J Neurol. 1995 Jan;242(2):112-4. doi: 10.1007/BF00887827.
9
Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report.
Psychiatry Res. 1991 Nov;40(3):195-202. doi: 10.1016/0925-4927(91)90010-n.
10
Positron emission tomographic studies of aging and Alzheimer disease.
AJNR Am J Neuroradiol. 1983 May-Jun;4(3):568-71.
Zotero 插件